Acetic Acid

SCHEMBL30219088

CC(=O)O.CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCSC)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2A ADRA2B ADRA2C ADRB2 AGTR1 AVPR1A AVPR1B AVPR2 BDKRB2 CALCR CHRNA3 CHRNB4 ESR1 ESR2 GHSR GNRHR GSC1 HSPA8 MALT1 MC1R MC4R NOS1 NOS2 NOS3 OPRK1 OXTR RAMP1 RAMP2 RAMP3 SCN5A SSTR1 SSTR2 SSTR3 SSTR4 SSTR5 dacA dacB dacC folP ftsI mrcA mrcB mrdA rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR known ✓	P30988	4/20	0.70

▸	MC4R known ✓	P32245	1/20	0.59

▸	GLP1R	P43220	8/20	0.67

▸	GCGR	P47871	5/20	0.67

▸	APLNR	P35414	2/20	0.62

▸	CRHR1	P34998	1/20	0.60

▸	CRHR2	Q13324	1/20	0.60

▸	CXCR4	P61073	1/20	0.59

▸	HCRTR1	O43613	1/20	0.59

▸	HCRTR2	O43614	1/20	0.59

▸	GIPR	P48546	2/20	0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Acetic Acid SCHEMBL30219069	1.00	CALCR (0.70)	CALCRGLP1RGCGRAPLNRCRHR1
Acetic Acid SCHEMBL30219038	0.99	CALCR (0.70)	CALCRGLP1RGCGRAPLNRCRHR1
Acetic Acid SCHEMBL30219057	0.99	CALCR (0.70)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL30219087	0.99	CALCR (0.71)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL30231481	0.99	CALCR (0.71)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL30231506	0.99	CALCR (0.71)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL30219064	0.99	CALCR (0.71)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL38659902	0.94	CALCR (0.67)	CALCRGLP1RGCGRAPLNRCRHR1
SCHEMBL30862308	0.93	CALCR (0.68)	CALCRGLP1RGCGRAPLNRCXCR4
SCHEMBL30524366	0.91	CALCR (0.70)	CALCRGLP1RGCGRAPLNRCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3046572-B1	CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF	BLAZE BIOSCIENCE INC (US)	2025-07-30	—	—	EP	disclosed
US-20250115648-A1	CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF	BLAZE BIOSCIENCE INC (US)	2025-04-10	—	—	US	disclosed
US-12048750-B2	Tissue-homing peptide conjugates and methods of use thereof	Blaze Bioscience, Inc. (US)	2024-07-30	—	—	US	disclosed
US-20230211000-A1	TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF	Blaze Bioscience, Inc.	2023-07-06	—	—	US	disclosed
US-11559580-B1	Tissue-homing peptide conjugates and methods of use thereof	Blaze Bioscience, Inc. (US)	2023-01-24	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-12048750-B2	Tissue-homing peptide conjugates and methods of use thereof	CXCL12, CCL2, CD44	CALCR 701/4885MC4R 988/4885GLP1R 1298/4885
US-20230211000-A1	TISSUE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF	CXCL12, CCL2, CD44	CALCR 701/4885MC4R 988/4885GLP1R 1298/4885
US-11559580-B1	Tissue-homing peptide conjugates and methods of use thereof	CXCL12, CCL2, CD44	CALCR 701/4885MC4R 988/4885GLP1R 1298/4885
US-20250115648-A1	CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF	CHLSN, QPCT, CBX6	CALCR 1052/4885MC4R 966/4885GLP1R 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.